Jacques Friborg
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, HIV Research and Treatment, Hepatitis B Virus Studies, Viral-associated cancers and disorders
Most-Cited Works
- → p53 inhibition by the LANA protein of KSHV protects against cell death(1999)706 cited
- → Propagation of a Human Herpesvirus from AIDS-Associated Kaposi's Sarcoma(1997)184 cited
- → Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)(2012)183 cited
- → Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions(2003)167 cited
- → Identification of I50L as the Signature Atazanavir (ATV)–Resistance Mutation in Treatment‐Naive HIV‐1–Infected Patients Receiving ATV‐Containing Regimens(2004)146 cited
- → Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization(2002)142 cited
- → The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)110 cited
- → Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir(2012)109 cited
- → Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema(1999)79 cited
- → IFN‐λ‐mediated IL‐12 production in macrophages induces IFN‐γ production in human NK cells(2014)68 cited